Prelude Therapeutics
Clinical trials sponsored by Prelude Therapeutics, explained in plain language.
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control CompletedThis early-stage study tested a new drug called PRT2527, both by itself and combined with other cancer drugs, in people with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatments sh…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial targets specific cancer gene mutation
Disease control CompletedThis first-in-human study tested a new drug called PRT3789, both alone and combined with the chemotherapy docetaxel, in people with advanced solid tumors that have a specific SMARCA4 gene mutation. The main goals were to find a safe dose, see how the body processes the drug, and …
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC